2005
DOI: 10.2310/6650.2005.00206.29
|View full text |Cite
|
Sign up to set email alerts
|

30HAEMOPHILUS INFLUENZAEFROM CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS WITH EXACERBATION INDUCES MORE INFLAMMATION THAN COLONIZERS

Abstract: Infection by nontypable Haemophilus influenzae in the airway causes inflammation, and newly isolated strains of these bacteria are associated with an increased risk of disease exacerbation in patients with chronic obstructive pulmonary disease (COPD). In this study we questioned whether strains of H. influenzae associated with exacerbations cause greater inflammation than strains colonizing airways of COPD patients. Bacterial strains were obtained from COPD patients that underwent serial assessment of clinical… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2009
2009

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Pulmonary inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), involve a complex network of cytokines and chemokines that can be differentially expressed depending on the type of disease, the state of exacerbation, or the presence or absence of a concurrent bacterial or viral infection 7, 14-20. Antibody array technology is a potentially powerful technique for pulmonary inflammatory disease research and diagnostics, as it can be used to define individual cytokine profiles for patients at different levels of disease control, and to evaluate treatment options and efficacy.…”
Section: Introductionmentioning
confidence: 99%
“…Pulmonary inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), involve a complex network of cytokines and chemokines that can be differentially expressed depending on the type of disease, the state of exacerbation, or the presence or absence of a concurrent bacterial or viral infection 7, 14-20. Antibody array technology is a potentially powerful technique for pulmonary inflammatory disease research and diagnostics, as it can be used to define individual cytokine profiles for patients at different levels of disease control, and to evaluate treatment options and efficacy.…”
Section: Introductionmentioning
confidence: 99%